Aurinia Pharmaceuticals
AUPH
#5063
Rank
NZ$2.28 B
Marketcap
$15.96
Share price
-0.11%
Change (1 day)
9.20%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -NZ$24.72 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.22 Billion. In 2023 the company made an earning of -NZ$0.14 Billion, an increase over its 2022 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$24.72 Million-81.28%
2023 -NZ$0.14 Billion-31.8%
2022 -NZ$0.2 Billion-39.4%
2021 -NZ$0.32 Billion61.9%
2020 -NZ$0.2 Billion-9.73%
2019 -NZ$0.22 Billion92.65%
2018 -NZ$0.12 Billion36.39%
2017 -NZ$83.18 Million106.29%
2016 -NZ$40.32 Million-15.4%
2015 -NZ$47.66 Million65.84%
2014 -NZ$28.74 Million129.82%
2013 -NZ$12.51 Million-26.6%
2012 -NZ$17.04 Million
2010 -NZ$9.65 Million-39.22%
2009 -NZ$15.87 Million-43.78%
2008 -NZ$28.23 Million-53.19%
2007 -NZ$60.31 Million42.97%
2006 -NZ$42.19 Million-23.03%
2005 -NZ$54.81 Million36.1%
2004 -NZ$40.28 Million172.57%
2003 -NZ$14.78 Million484.61%
2002 -NZ$2.53 Million
2000 -NZ$12 Million453.81%
1999 -NZ$2.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$8.78 B-32,918.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.7 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$39.1 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA